期刊文献+

抗肿瘤药格列卫的合成工艺研究 被引量:2

Synthesis of Antitummer Drug Gleevec
下载PDF
导出
摘要 采用2-溴-4-氨基甲苯为原料,与中间体4-(4-甲基哌嗪-1-甲基)苯甲酰氯发生酰胺化反应,继而与中间体4-(3-吡啶基)-2-氨基-嘧啶发生取代反应,最后与甲磺酸成盐共3步反应制得标题化合物。本路线操作简单、成本较低、条件温和、步骤少,适合工业化生产,总收率59.6%。 Gleevec was synthesized from 3-Bromo-4-methylaniline and 4-(4-methyl-piperazin-l-ylmethyl)-benzoyl chloride and 4-Pyridin-3-yl-pyrimidin-2-ylamine via amidation and substitution reaction. This improved method can be used in industrial manufacturing with the advantage of simple purifying operation, lower cost and mild condition. The total yield was 59.6%.
出处 《化学试剂》 CAS CSCD 北大核心 2014年第6期574-576,共3页 Chemical Reagents
关键词 格列卫 合成工艺 抗肿瘤药 Gleevec chemical synthesis antitummer drug
  • 相关文献

参考文献8

  • 1SCHINDLER T,BORNMANN W,PELLICENA P,et al.Struettzml mechanism for STI-571 inhibition of abelson tyrosine kinase [J].Science,2000,289(5 486):1 857-1 859. 被引量:1
  • 2GURE Z.Crystal modification of a N,phenyi-2-pyrim-dlneamine derivative,processes for facture and its use:WO,9 903 854 [P].1999-01-28. 被引量:1
  • 3MANLEY P W,BREITENSTEIN W,BRUGGEN J,et al.Urea derivatiws-af STt571 as inhibitors of Bcr-Abl and PDCFR kinases [J].Bioorg.Med.Chem.Lett.,2004,14(23):5 793-5 797. 被引量:1
  • 4许鹏飞,张春桃.甲磺酸伊马替尼合成新工艺[J].应用技术,2006,14(12):958-960. 被引量:1
  • 5付利强,王鹏,程卯生,赵冬梅.甲磺酸伊马替尼合成路线图解[J].中国医药工业杂志,2008,39(10):786-788. 被引量:8
  • 6李铭东,李东,吉民.甲磺酸伊马替尼的合成[J].中国药学杂志,2008,43(3):228-229. 被引量:19
  • 7SAIRAM P,PURANIK R,KELKAR A S,et at.The ester and amide derivatives of 4-(4-methyl piperazinomethyl)benzoic acid [J].Synth.Commun.,2003,33:3 597-605. 被引量:1
  • 8LIU Yi-feng,WANG Cui-ling,BAI Ya-jun,et al.A facile totat synthesis of imatinib base and its analogues [J].Org.Process.Res.D.,2008,12(3):490-495. 被引量:1

二级参考文献26

  • 1陈敖,黄荷香,宋帅娟,陈小琴.甲磺酸伊马替尼的合成[J].精细与专用化学品,2007,15(8):23-25. 被引量:11
  • 2JURG Z, WALLBACH. Pyrimidine derivatives and processes for the preparation thereof: US,5521184[ P]. 1996-05-28. 被引量:1
  • 3JOHN P D, JAY D A. Substituted pyrazolo (1,5-A) pyrimidines and their use as anxiolytic agents: US,004281000 [ P]. 1982-07-28. 被引量:1
  • 4PAUL W M, WERNER B, JOSEF B. Urea derivatives of ST1571 as inhibitors of Bcr-Abl and PDGFR kinases [ J ]. Bioorg Med Chem Lett,2004, 14 : 5793-5797. 被引量:1
  • 5JURG Z. Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for facture and its use: WO,9903854[ P]. 1999-01-28. 被引量:1
  • 6Schindler T, Bornmann W, Pellicena P, et al. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase [J]. Science, 2000, 289 (5486) : 1857-1859. 被引量:1
  • 7Zimmermann J, Caravatti G, Mett H, et al. Phenylaminopyrimidine (PAP) derivatives: a new class of potant and selective inhibitors of protein kinase C (PKC) [J]. Arch Pharm (Weinheim), 1996, 329 (7): 371-376. 被引量:1
  • 8Zimmermann J, Buchdunger E, Mett H, et al. Phenylaminopyrimidine (PAP)-derivertives :a new class of potant and highly selective PDGF-receptor autophosphorylation inhibitors [J].Bioorg Med Chem Lett, 1996, 6(11): 1221-1226. 被引量:1
  • 9Szakacs Z, Beni S, Varga Z, et al. Acid-base profiling of imatinib (gleevec) and its fragments [J]. J Med Chem, 2005, 48 (1): 249-255. 被引量:1
  • 10Kim DY, Kim JG, Cho DJ, et al.N-Phenyl-2-pyrimidineamine derivatives and process forthe preparation thereof: WO, 20040099186 [P].2004-11-18. (CA 2004, 141 424204) 被引量:1

共引文献24

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部